GLP-1 drugs , or glucagon-like peptide-1 compounds, represent a substantial development in how we approach type 2 diabetes . These new drugs work by imitating the body’s own GLP-1 process, which https://rorywfme557722.designertoblog.com/73424003/glp-1-a-major-breakthrough-in-glucose-management